The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …

Abstract The Japanese Society of Gastroenterology revised the evidence-based clinical
practice guidelines for liver cirrhosis in 2015. Eighty-three clinical questions were selected …

中华医学会肝病学分会根据已发表的证据和专家共识, 制定了当前肝硬化诊治指南,
旨在进一步改善临床实践. 该指南不包括既往系列肝硬化并发症指南中已有的内容 …

The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …

Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in
the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in …

Gastroesophageal varices are present at diagnosis in almost half of patients with cirrhosis,
and variceal hemorrhage continues to be a lethal complication of cirrhosis. This review …

Based on reviews of the literature and experts' consensus, the Chinese Society of
Hepatology developed guidelines for the diagnosis and treatment of liver cirrhosis, in order …

In patients with variceal bleeding as a complication of hepatic cirrhosis, propranolol therapy
reduces the risk of recurrent variceal haemorrhage. However, the relation between portal …

Variceal bleeding is the last step in a chain of events initiated by an increase in portal
pressure, followed by the development and progressive dilation of varices until these finally …